Terms: = Colorectal cancer AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL
6637 results:
1. The Relationship of Microsatellite Instability with BRAF and p53 Mutations and Histopathological Parameters in colorectal Adenocarcinoma.
Gündoğar Ö; Bektaş S; Yıldırım E; Gönüllü D
Ann Ital Chir; 2024; 95(2):181-191. PubMed ID: 38684491
[TBL] [Abstract] [Full Text] [Related]
2. The influence of home versus clinic anal human papillomavirus sampling on high-resolution anoscopy uptake in the Prevent Anal cancer Self-Swab Study.
Nitkowski J; Ridolfi TJ; Lundeen SJ; Giuliano AR; Chiao EY; Fernandez ME; Schick V; Smith JS; Brzezinski B; Nyitray AG
Sex Health; 2024 Apr; 21():. PubMed ID: 38683939
[TBL] [Abstract] [Full Text] [Related]
3. H
Qiao L; Ou Y; Li L; Wu S; Guo Y; Liu M; Yu D; Chen Q; Yuan J; Wei C; Ou C; Li H; Cheng D; Yu Z; Li Z
J Nanobiotechnology; 2024 Apr; 22(1):205. PubMed ID: 38658965
[TBL] [Abstract] [Full Text] [Related]
4. Microenvironment, systemic inflammatory response and tumor markers considering consensus molecular subtypes of colorectal cancer.
Jakab A; Patai ÁV; Darvas M; Tormássi-Bély K; Micsik T
Pathol Oncol Res; 2024; 30():1611574. PubMed ID: 38645565
[No Abstract] [Full Text] [Related]
5. Identifying social determinants of health from clinical narratives: A study of performance, documentation ratio, and potential bias.
Yu Z; Peng C; Yang X; Dang C; Adekkanattu P; Gopal Patra B; Peng Y; Pathak J; Wilson DL; Chang CY; Lo-Ciganic WH; George TJ; Hogan WR; Guo Y; Bian J; Wu Y
J Biomed Inform; 2024 May; 153():104642. PubMed ID: 38621641
[TBL] [Abstract] [Full Text] [Related]
6. Ultrasound-guided stellate ganglion block benefits the postoperative recovery of patients undergoing laparoscopic colorectal surgery: a single-center, double-blinded, randomized controlled clinical trial.
Lu DH; Xu XX; Zhou R; Wang C; Lan LT; Yang XY; Feng X
BMC Anesthesiol; 2024 Apr; 24(1):137. PubMed ID: 38600490
[TBL] [Abstract] [Full Text] [Related]
7. Stage at diagnosis of colorectal cancer through diagnostic route: Who should be screened?
Agatsuma N; Utsumi T; Nishikawa Y; Horimatsu T; Seta T; Yamashita Y; Tanaka Y; Inoue T; Nakanishi Y; Shimizu T; Ohno M; Fukushima A; Nakayama T; Seno H
World J Gastroenterol; 2024 Mar; 30(10):1368-1376. PubMed ID: 38596494
[TBL] [Abstract] [Full Text] [Related]
8. [Expression of immune checkpoints PD-L1, CTLA4, LAG3 in the microenvironment of colon adenocarcinoma depending on MMR status].
Naumov SS; Krakhmal NV; Tashireva LA; Vtorushin SV
Arkh Patol; 2024; 86(2):6-13. PubMed ID: 38591901
[TBL] [Abstract] [Full Text] [Related]
9. Intracorporeal versus extracorporeal anastomosis in laparoscopic right hemicolectomy for overweight colon cancer patients: a case-control study.
Zhou D; Su J; Yang X; Huang L; Zheng Z; Wei H; Fang J
Langenbecks Arch Surg; 2024 Apr; 409(1):112. PubMed ID: 38587671
[TBL] [Abstract] [Full Text] [Related]
10. A cross-sectional study of sleep disturbance among middle-aged cancer patients at Vietnam National cancer Hospital.
Pham AT; Do MT; Tran HTT
Cancer Rep (Hoboken); 2024 Apr; 7(4):e2055. PubMed ID: 38577715
[TBL] [Abstract] [Full Text] [Related]
11. Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study.
Ercan AB; Aronson M; Fernandez NR; Chang Y; Levine A; Liu ZA; Negm L; Edwards M; Bianchi V; Stengs L; Chung J; Al-Battashi A; Reschke A; Lion A; Ahmad A; Lassaletta A; Reddy AT; Al-Darraji AF; Shah AC; Van Damme A; Bendel A; Rashid A; Margol AS; Kelly BL; Pencheva B; Heald B; Lemieux-Anglin B; Crooks B; Koschmann C; Gilpin C; Porter CC; Gass D; Samuel D; Ziegler DS; Blumenthal DT; Kuo DJ; Hamideh D; Basel D; Khuong-Quang DA; Stearns D; Opocher E; Carceller F; Baris Feldman H; Toledano H; Winer I; Scheers I; Fedorakova I; Su JM; Vengoechea J; Sterba J; Knipstein J; Hansford JR; Gonzales-Santos JR; Bhatia K; Bielamowicz KJ; Minhas K; Nichols KE; Cole KA; Penney L; Hjort MA; Sabel M; Gil-da-Costa MJ; Murray MJ; Miller M; Blundell ML; Massimino M; Al-Hussaini M; Al-Jadiry MF; Comito MA; Osborn M; Link MP; Zapotocky M; Ghalibafian M; Shaheen N; Mushtaq N; Waespe N; Hijiya N; Fuentes-Bolanos N; Ahmad O; Chamdine O; Roy P; Pichurin PN; Nyman P; Pearlman R; Auer RC; Sukumaran RK; Kebudi R; Dvir R; Raphael R; Elhasid R; McGee RB; Chami R; Noss R; Tanaka R; Raskin S; Sen S; Lindhorst S; Perreault S; Caspi S; Riaz S; Constantini S; Albert S; Chaleff S; Bielack S; Chiaravalli S; Cramer SL; Roy S; Cahn S; Penna S; Hamid SA; Ghafoor T; Imam U; Larouche V; Magimairajan Issai V; Foulkes WD; Lee YY; Nathan PC; Maruvka YE; Greer MC; Durno C; Shlien A; Ertl-Wagner B; Villani A; Malkin D; Hawkins C; Bouffet E; Das A; Tabori U
Lancet Oncol; 2024 May; 25(5):668-682. PubMed ID: 38552658
[TBL] [Abstract] [Full Text] [Related]
12. Mismatch repair protein deficiency and its implications on distant metastasis in colorectal cancer: A comprehensive analysis.
Fan C; Fang C; Wang W; Lv Z; Zhang X; Long F; Jiang Z; Li Y; Zhang H; Zhou ZG; Wang C; Sun XF
Cancer Med; 2024 Apr; 13(7):e6994. PubMed ID: 38545852
[TBL] [Abstract] [Full Text] [Related]
13. Association between microsatellite status and characteristics and outcomes of early-onset compared to late-onset rectal cancer.
Emile SH; Horesh N; Garoufalia Z; Gefen R; Zhou P; Strassmann V; Wexner SD
Int J Colorectal Dis; 2024 Mar; 39(1):43. PubMed ID: 38538931
[TBL] [Abstract] [Full Text] [Related]
14. A multicenter study evaluating efficacy of immune checkpoint inhibitors in advanced non-colorectal digestive cancers with microsatellite instability.
Moreau M; Alouani E; Flecchia C; Falcoz A; Gallois C; Auclin E; André T; Cohen R; Hollebecque A; Turpin A; Pernot S; Masson T; Di Fiore F; Dutherge M; Mazard T; Hautefeuille V; Van Laethem JL; De la Fouchardière C; Perkins G; Ben-Abdelghani M; Sclafani F; Aparicio T; Kim S; Vernerey D; Taieb J; Guimbaud R; Tougeron D
Eur J Cancer; 2024 May; 202():114033. PubMed ID: 38537314
[TBL] [Abstract] [Full Text] [Related]
15. A Validated Highly Sensitive Microsatellite Instability Assay Accurately Identifies Individuals Harboring Biallelic Germline pms2 Pathogenic Variants in Constitutional Mismatch Repair Deficiency.
Marín F; Canet-Hermida J; Bianchi V; Chung J; Wimmer K; Foulkes W; Pérez-Alonso V; Domínguez-Pinilla N; Sábado C; Vázquez-Gómez F; Molinés A; Fioravantti V; Carrasco E; Stengs L; Edwards M; Negm L; Das A; Aronson M; Pastor Á; Rueda D; González-Granado LI; Tabori U; Capellá G; Pineda M
Clin Chem; 2024 May; 70(5):737-746. PubMed ID: 38531023
[TBL] [Abstract] [Full Text] [Related]
16. Epigenetic MLH1 silencing concurs with mismatch repair deficiency in sporadic, naturally occurring colorectal cancer in rhesus macaques.
Deycmar S; Johnson BJ; Ray K; Schaaf GW; Ryan DP; Cullin C; Dozier BL; Ferguson B; Bimber BN; Olson JD; Caudell DL; Whitlow CT; Solingapuram Sai KK; Romero EC; Villinger FJ; Burgos AG; Ainsworth HC; Miller LD; Hawkins GA; Chou JW; Gomes B; Hettich M; Ceppi M; Charo J; Cline JM
J Transl Med; 2024 Mar; 22(1):292. PubMed ID: 38504345
[TBL] [Abstract] [Full Text] [Related]
17. Silver nanoparticles stimulate 5-Fluorouracil-induced colorectal cancer cells to kill through the upregulation TRPV1-mediated calcium signaling pathways.
Kaya MM
Cell Biol Int; 2024 May; 48(5):712-725. PubMed ID: 38499507
[TBL] [Abstract] [Full Text] [Related]
18. Cardiovascular/anti-inflammatory drugs repurposed for treating or preventing cancer: A systematic review and meta-analysis of randomized trials.
Benjamin DJ; Haslam A; Prasad V
Cancer Med; 2024 Mar; 13(5):e7049. PubMed ID: 38491813
[TBL] [Abstract] [Full Text] [Related]
19. Modified FOLFOX6 plus bevacizumab with and without nivolumab for first-line treatment of metastatic colorectal cancer: phase 2 results from the CheckMate 9X8 randomized clinical trial.
Lenz HJ; Parikh A; Spigel DR; Cohn AL; Yoshino T; Kochenderfer M; Elez E; Shao SH; Deming D; Holdridge R; Larson T; Chen E; Mahipal A; Ucar A; Cullen D; Baskin-Bey E; Kang T; Hammell AB; Yao J; Tabernero J
J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38485190
[TBL] [Abstract] [Full Text] [Related]
20. The choice of diagnostic modality influences the proportion of low muscle strength, low muscle mass, and sarcopenia in colorectal cancer patients.
Berg HB; Alavi DT; Beichmann B; Pesonen M; Henriksen C; Paur I; Bøhn SK; Lauritzen PM; Blomhoff R; Henriksen HB
Clin Nutr ESPEN; 2024 Apr; 60():17-23. PubMed ID: 38479906
[TBL] [Abstract] [Full Text] [Related]
[Next]
